You searched for "Ear"
Hearing implant devices: new expectations during IFOS 2023 ENT World Congress, Dubai
We hear from one of the senior members of the IFOS Executive Board about the aspects of IFOS that he is looking forward to – and, in particular, his focus on implantable hearing devices. From 17 to 21 January 2023,...Where ignorance is bliss, 'tis folly to be wise
Our irrepressible Features Editor, Chris Potter, explores the limits of ignorance. I’m not sure about you, but I seem to exist in a sea of incompetence and ignorance, constantly surrounded by amateurish chumps and feckless underachievers. Now, a lesser man...Vestibular rehabilitation therapy: diagnosis based strategies
In his second article on this topic (see here for the first article), Richard E Gans explains how to use vestibular rehabilitation therapy to treat vestibular patients, and demonstrates why this method of diagnosis based strategies has proved so successful....In conversation with Professor Bill Gibson: When a Padawan meets his master again
“It was a privilege to have conducted an interview with Professor Gibson, my mentor and teacher, during the six months I was the Graham Fraser Foundation (GFF) Fellow in Sydney in 2005. Twelve years later, I am absolutely delighted to...Editorial moves
Many congratulations to two members of the ENT & Audiology News team who have been given new roles.34th Congress of the Nordic Association of Otolaryngology
This triennial congress has provided a forum for otorhinolaryngologists in the Nordic countries to exchange knowledge and learn from each other for more than a century. Originally planned for 2020, this year's congress will bring together experts from the Nordic...
BPPV duration as a predictor for therapy
Benign paroxysmal positional vertigo (BPPV) is one of the most common vestibuar disorders encountered in the neurotology clinic. The majority of cases of BPPV are due to vestibuar lithiasis in the posterior semicircular canal, but there are reports of cases...
High dose betahistine as effective as, but slower acting compared to intratympanic dexamethasone in intractable Meniere’s disease
The management of intractable Meniere’s disease poses a complex conundrum to otolaryngologists. The focus of treatment is decreasing the severity and frequency of vertigo and tinnitus whilst trying to preserve hearing. Betahistine has been used for many years in the...
A future for unilateral deafness
Every year, we see several patients struggling with irreversible unilateral hearing loss that is non-responsive to sound amplification. This article emphasises that clinicians should not underestimate the functional and psychological impairment single-sided deafness can have on an individual, even though...
